title: Morbidity after induction therapy and surgery in non small cell lung cancer (NSCLC). Focus on pulmonary function.
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Granone
authors.forename: Alfredo
authors.initials: A
authors.lastname: Cesario
authors.forename: Stefano
authors.initials: S
authors.lastname: Margaritora
authors.forename: Domenico
authors.initials: D
authors.lastname: Galetta
authors.forename: Salvatore
authors.initials: S
authors.lastname: Valente
authors.forename: Giuseppe Maria
authors.initials: GM
authors.lastname: Corbo
authors.forename: Giorgio
authors.initials: G
authors.lastname: Fumagalli
authors.forename: Lucio
authors.initials: L
authors.lastname: Trodella
authors.forename: Rolando Maria
authors.initials: RM
authors.lastname: D'Angelillo
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D009017:Morbidity; D011879:Radiotherapy Dosage; D012074:Remission Induction; D012129:Respiratory Function Tests